These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes. Zabarovskaja S, Hage C, Linde C, Daubert JC, Donal E, Gabrielsen A, Mellbin L, Lund LH. Int J Cardiol; 2015 Dec; 189():6-11. PubMed ID: 25885866 [Abstract] [Full Text] [Related]
16. Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial. Travaglino F, Russo V, De Berardinis B, Numeroso F, Catania P, Cervellin G, Nigra SG, Geraci F, Bressan MA, Guerrini S, Cavazza M, Folli C, Monzani V, Battista S, Mengozzi G, Noto P, Carpinteri G, Semplicini A, Stella F, Ingrassia S, Moscatelli P, Giuntini P, Salerno G, Cardelli P, Di Somma S. Am J Emerg Med; 2014 Apr; 32(4):334-41. PubMed ID: 24559907 [Abstract] [Full Text] [Related]
17. Mid-regional pro-adrenomedullin outperforms N-terminal pro-B-type natriuretic peptide for the diagnosis of acute heart failure in the presence of atrial fibrillation. Kuan WS, Ibrahim I, Chan SP, Li Z, Liew OW, Frampton C, Troughton R, Pemberton CJ, Chong JPC, Tan LL, Lin W, Ooi SBS, Richards AM. Eur J Heart Fail; 2020 Apr; 22(4):692-700. PubMed ID: 31808279 [Abstract] [Full Text] [Related]